Estimating Australian Population Utilities for Inherited Retinal Disease Using Time Trade-Off [0.03%]
使用时间交易法估算遗传性视网膜疾病患者的澳大利亚人口效用值
Maria Farris,Stephen Goodall,Richard De Abreu Lourenco et al.
Maria Farris et al.
Purpose: Inherited retinal disease (IRD) causes progressive loss of visual function, degenerating towards complete blindness. Economic evaluation of gene therapies for rare forms of genetic IRDs have had to rely on health...
Correction: Cost-Effectiveness of Dupilumab and Oral Janus Kinase Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis in Singapore [0.03%]
关于杜匹鲁单抗和口服 janus 激酶抑制剂治疗新加坡中重度特应性皮炎的成本效益的更正通知
Clarence Ong,Jamaica Briones,Zhi Zhen Lim et al.
Clarence Ong et al.
Published Erratum
PharmacoEconomics - open. 2024 Nov;8(6):961. DOI:10.1007/s41669-024-00516-4 2024
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study [0.03%]
随访抗逆转录病毒治疗成本效益的队列和成本效用研究
Matilde Slot,Thomas Bøjer Rasmussen,Mette Nørgaard et al.
Matilde Slot et al.
Objective: To estimate the costs and cost-effectiveness of introducing highly active antiretroviral therapy (HAART) in Denmark based on real-world evidence for the three treatment eras pre-HAART (1985-1995), early HAART (...
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story [0.03%]
价值驱动型医疗策略对生物类似药采用的影响：新加坡案例分析
She Hui Tan,Louise Gek Huang Goh,Benjamin Shao Kiat Ong et al.
She Hui Tan et al.
Background: Healthcare sustainability is a global challenge. Various value-driven healthcare strategies have been implemented by Singapore's national health technology assessment (HTA) agency, the Agency for Care Effectiv...
Correction: Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older [0.03%]
修正：加拿大50岁及以上成年人重组水痘带状疱疹疫苗的公共卫效应和成本效果更新分析
Sydney George,Justin Carrico,Katherine A Hicks et al.
Sydney George et al.
Published Erratum
PharmacoEconomics - open. 2024 Sep;8(5):785. DOI:10.1007/s41669-024-00502-w 2024
Cost-Effectiveness of Dupilumab and Oral Janus Kinase Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis in Singapore [0.03%]
dupilumab和口服janus激酶抑制剂治疗新加坡中重度特应性皮炎的成本效益分析
Clarence Ong,Jamaica Briones,Zhi Zhen Lim et al.
Clarence Ong et al.
Background: Atopic dermatitis (AD) affects both adults and children, impacting their quality of life and productivity; however, traditional systemic treatments such as cyclosporine have limitations. Emerging novel systemi...
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina [0.03%]
奥拉帕利在阿根廷用于同源重组修复基因突变的转移性去势抵抗性前列腺癌患者治疗中的预算影响分析
Natalia Espinola,Constanza Silvestrini,Carla Colaci et al.
Natalia Espinola et al.
Objectives: The aim of this study was to perform a budget impact analysis (BIA) of introducing olaparib treatment for adult patients with metastatic castration-resistant prostate cancer in Argentina. ...
ENTIMOS: Decision Support Tool Highlights Potential Impact of Non-intravenous Therapies for Multiple Sclerosis on Patient Care via Clinical Scenario Simulation [0.03%]
ENTIMOS：决策支持工具通过临床场景模拟突出多种非静脉注射疗法对多发性硬化症患者护理潜在影响的亮点
Richard Nicholas,Erik Scalfaro,Rachel Dorsey et al.
Richard Nicholas et al.
Introduction: Administration of intravenous (IV), high-efficacy treatments (HETs) for the treatment of multiple sclerosis (MS) poses a high resourcing and planning burden on infusion centres, resulting in treatment delays...
Using a Patient-Centered Multicriteria Decision Analysis to Assess the Value of Multiple Sclerosis Treatments in the US: A Study Protocol [0.03%]
在美国使用以患者为中心的多标准决策分析来评估美国多发性硬化症治疗的价值：一项研究方案
Surachat Ngorsuraches,Tim C Lai,Rebecca Habermann et al.
Surachat Ngorsuraches et al.
Objective: The engagement of patients and family caregivers in value assessment is pivotal since they provide valuable contributions to assessment acceptability and relevance. The proposed study aims to use patient-center...
Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata [0.03%]
斑块型银屑病患者EQ-5D-5L的计量学特征分析
Andrew Lloyd,Daniel Aggio,Caleb Dixon et al.
Andrew Lloyd et al.
Background: For many decision makers in Health Technology Assessment the EQ-5D-5L is the standard measure of health-related quality of life (HRQL). However, evidence has shown the limitations of the measure in certain dis...